Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We aimed to determine the association between SNPs in the vitamin D gene cascade and response to pegylated interferon (PegIFN) therapy in hepatitis B e-antigen (HBeAg)-positive patients.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study

Study design awaiting verification · PLoS ONE · 2017

Original publication title

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study

Kessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjareon; Tawesak Tanwandee; Phunchai Charatcharoenwitthaya; Satawat Thongsawat; Apinya Leerapun; Teerha Piratvisuth; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Chaowalit Pattanasirigool; Bubpha Pornthisarn; Supot Tantipanichtheerakul; Ekawee Sripariwuth; Woramon Jeamsripong; Teeranan Sanpajit; Yong Poovorawan; Piyawat Komolmit

© 2017 Thanapirom et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Evidence of a role of vitamin D in the immune system is increasing. Low serum vitamin D is associated with increased hepatitis B virus replication. Genome-wide association study (GWAS) data has revealed a number of the single nucleotide polymorphisms (SNPs) within the vitamin D synthetic pathway that affect vitamin D functions. We aimed to determine the association between SNPs in the vitamin D gene cascade and response to pegylated interferon (PegIFN) therapy in hepatitis B e-antigen (HBeAg)-positive patients. One hundred and eleven patients treated for 48 weeks with PegIFN-alfa 2a at 13 hospitals were retrospectively evaluated.

Thirteen SNPs derived from vitamin D cascade-related genes, including DHCR7 (rs12785878), CYP27B1 (rs10877012), CYP2R1 (rs2060793, rs12794714), GC (rs4588, rs7041, rs222020, rs2282679), and VDR (FokI, BsmI, Tru9I, ApaI, TaqI), were genotyped. Thirty-one patients (27.9%) seroconverted to HBeAg after 24 weeks of treatment. Multivariate analysis found pretreatment qHBsAg <10,000 IU/mL (OR = 7.73, 95% CI: 2.36 to 25.31, P = 0.001), CYP2R1 rs12794714 TT genotype (OR = 4.16, 95% CI: 1.07 to 16.25, P = 0.04), and baseline ALT >2 times the upper limit of normal (OR = 3.83, 95% CI: 1.31 to 11.22, P = 0.014) predicted sustained HBeAg seroconversion after completion of PegIFN treatment.

HBV DNA during study period tended to be lower with the rs12794714 CYP2R1 TT than the non-TT genotype. The rs12794714 CYP2R1 polymorphism may be a useful pretreatment factor predictive of sustained HBeAg seroconversion after PegIFN therapy. This study provides evidence that not only vitamin D level but also genetic variation of CYP2R1 in the vitamin D cascade influences host immune response in chronic HBV infection.

Authors’ abstract

Evidence of a role of vitamin D in the immune system is increasing. Low serum vitamin D is associated with increased hepatitis B virus replication. Genome-wide association study (GWAS) data has revealed a number of the single nucleotide polymorphisms (SNPs) within the vitamin D synthetic pathway that affect vitamin D functions. We aimed to determine the association between SNPs in the vitamin D gene cascade and response to pegylated interferon (PegIFN) therapy in hepatitis B e-antigen (HBeAg)-positive patients. One hundred and eleven patients treated for 48 weeks with PegIFN-alfa 2a at 13 hospitals were retrospectively evaluated.

Thirteen SNPs derived from vitamin D cascade-related genes, including DHCR7 (rs12785878), CYP27B1 (rs10877012), CYP2R1 (rs2060793, rs12794714), GC (rs4588, rs7041, rs222020, rs2282679), and VDR (FokI, BsmI, Tru9I, ApaI, TaqI), were genotyped. Thirty-one patients (27.9%) seroconverted to HBeAg after 24 weeks of treatment. Multivariate analysis found pretreatment qHBsAg <10,000 IU/mL (OR = 7.73, 95% CI: 2.36 to 25.31, P = 0.001), CYP2R1 rs12794714 TT genotype (OR = 4.16, 95% CI: 1.07 to 16.25, P = 0.04), and baseline ALT >2 times the upper limit of normal (OR = 3.83, 95% CI: 1.31 to 11.22, P = 0.014) predicted sustained HBeAg seroconversion after completion of PegIFN treatment.

HBV DNA during study period tended to be lower with the rs12794714 CYP2R1 TT than the non-TT genotype. The rs12794714 CYP2R1 polymorphism may be a useful pretreatment factor predictive of sustained HBeAg seroconversion after PegIFN therapy. This study provides evidence that not only vitamin D level but also genetic variation of CYP2R1 in the vitamin D cascade influences host immune response in chronic HBV infection.

Publication and source details

Original title: Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study

Kessarin Thanapirom; Sirinporn Suksawatamnuay; Wattana Sukeepaisarnjareon; Tawesak Tanwandee; Phunchai Charatcharoenwitthaya; Satawat Thongsawat; Apinya Leerapun; Teerha Piratvisuth; Rattana Boonsirichan; Chalermrat Bunchorntavakul; Chaowalit Pattanasirigool; Bubpha Pornthisarn; Supot Tantipanichtheerakul; Ekawee Sripariwuth; Woramon Jeamsripong; Teeranan Sanpajit; Yong Poovorawan; Piyawat Komolmit

PLoS ONE · 2017

Competing Interests: All authors have declared that no competing interests exist.

  • Conceptualization: KT SS YP PK.

  • Data curation: KT WS TT PC S. Tantipanichtheerakul AL TP RB CB CP BP S. Thongsawat ES WJ TS PK.

  • Formal analysis: KT SS WS PC YP PK.

  • Funding acquisition: TT TP PK.

  • Investigation: KT WS TT PC S. Tantipanichtheerakul AL TP RB CB CP BP S. Thongsawat ES WJ TS PK.

  • Methodology: KT SS YP PK.

  • Project administration: PK.

  • Resources: KT WS TT PC S. Tantipanichtheerakul AL TP RB CB CP BP S. Thongsawat ES WJ TS PK.

  • Software: KT.

  • Supervision: PK.

  • Validation: KT SS WS PC YP PK.

  • Visualization: KT SS WS PC YP PK.

  • Writing: original draft: KT SS WS PC YP PK.

  • Writing: review & editing: PC YP PK.

* E-mail: pkomolmit@yahoo.co.uk
© 2017 Thanapirom et al2017Thanapirom et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Thai association for the study of the liver (THASL)Komolmit Piyawat Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff"CU’s SRP_05_55_30_01Komolmit Piyawat The National research Council of Thailand (NRCT)Poovorawan Yong The Research Chair Grant from the National Science and Technology Development Agency, The Center of Excellence in Clincal Virology of Chulalongkorn UniversityGCE 58-014-30-004Poovorawan Yong The pericardia Program of the Royal College of Physicians of ThailandThanapirom Kessarin The research funding was supported by Thai Association for the Study of the Liver (THASL), the Ratchadaphiseksomphot Endowment Fund Part of the “Grants for Junior or Terminated Executive staff” (CU’s SRP_05_55_30_01), the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (RA55/24) and the Pericardia Program of The Royal College of Physicians of Thailand. Part or partial of the laboratory work was supported by The National Research Council of Thailand (NRCT), The Research Chair Grant from the National Science and Technology Development Agency, The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 58-014-30-004) and King Chulalongkorn Memorial Hospital.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:14:37.520108+00:00

DOI: 10.1371/journal.pone.0173263 · PMC5351865